The time investment of 4 additional weeks at an intermediate dose is nothing compared to the setback of severe nausea that forces you to restart at a lower dose
Acknowledgements The authors thank M
For those who benefit from additional structure, meal replacement options may be suggested to help with portion control and nutrient intake
For most patients, no because the gap between your last semaglutide dose and your first tirzepatide dose is typically just one week
The constellation of risk factor improvements provides reasonable expectation of cardiovascular benefit that formal trials may confirm
Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, et al